Mohmmed Hegab, A.M.; Hassanin, S.O.; Mekky, R.H.; Abuzahrah, S.S.; Hamza, A.A.; Talaat, I.M.; Amin, A.
Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1/Nrf2, Oxidative Stress, Inflammation, and Apoptosis. Pharmaceuticals 2025, 18, 248.
https://doi.org/10.3390/ph18020248
AMA Style
Mohmmed Hegab AM, Hassanin SO, Mekky RH, Abuzahrah SS, Hamza AA, Talaat IM, Amin A.
Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1/Nrf2, Oxidative Stress, Inflammation, and Apoptosis. Pharmaceuticals. 2025; 18(2):248.
https://doi.org/10.3390/ph18020248
Chicago/Turabian Style
Mohmmed Hegab, Amany Mohammed, Soha Osama Hassanin, Reham Hassan Mekky, Samah Sulaiman Abuzahrah, Alaaeldin Ahmed Hamza, Iman M. Talaat, and Amr Amin.
2025. "Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1/Nrf2, Oxidative Stress, Inflammation, and Apoptosis" Pharmaceuticals 18, no. 2: 248.
https://doi.org/10.3390/ph18020248
APA Style
Mohmmed Hegab, A. M., Hassanin, S. O., Mekky, R. H., Abuzahrah, S. S., Hamza, A. A., Talaat, I. M., & Amin, A.
(2025). Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1/Nrf2, Oxidative Stress, Inflammation, and Apoptosis. Pharmaceuticals, 18(2), 248.
https://doi.org/10.3390/ph18020248
